Emzor Pharmaceutical Industries Ltd:企業の戦略的SWOT分析

◆英語タイトル:Emzor Pharmaceutical Industries Ltd - Strategic SWOT Analysis Review
◆商品コード:DATA904C12940
◆発行会社(調査会社):GlobalData
◆発行日:2019年1月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ナイジェリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Emzor Pharmaceutical Industries Ltd – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Emzor Pharmaceutical Industries Ltd (Emzor), a subsidiary of Emzor Chemists Limited, is a pharmaceutical company that develops, manufactures and markets pharmaceutical products and medical consumables. The company provides analgesics, anti-inflammatries, antibiotics, anti-malarials, haematinics, and vitamins and dietary supplements. Emzor provides products in various forms such as syrups, oils, drops and tablets, among others. The company’s offers its products under Emtrim, Emcillin, Emrozon, Ferrous, Paracetamol, Emzolyn, Lokmal, Maldox Fresh Seas and Omega 3 and other brands. The company has offices in Nigeria, Liberia, India, Mali, Ghana and Sierra Leone. Emzor is headquartered in Lagos, Nigeria.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
Section 1 – About the Company 5
Emzor Pharmaceutical Industries Ltd – Key Facts 5
Emzor Pharmaceutical Industries Ltd – Key Employees 6
Emzor Pharmaceutical Industries Ltd – Key Employee Biographies 7
Emzor Pharmaceutical Industries Ltd – Major Products and Services 8
Emzor Pharmaceutical Industries Ltd – History 10
Emzor Pharmaceutical Industries Ltd – Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2 – Company Analysis 12
Company Overview 12
Emzor Pharmaceutical Industries Ltd – Business Description 13
Emzor Pharmaceutical Industries Ltd – SWOT Analysis 14
SWOT Analysis – Overview 14
Emzor Pharmaceutical Industries Ltd – Strengths 14
Emzor Pharmaceutical Industries Ltd – Weaknesses 15
Emzor Pharmaceutical Industries Ltd – Opportunities 16
Emzor Pharmaceutical Industries Ltd – Threats 17
Emzor Pharmaceutical Industries Ltd – Key Competitors 18
Section 3 – Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Emzor Pharmaceutical Industries Ltd, Key Facts 5
Emzor Pharmaceutical Industries Ltd, Key Employees 6
Emzor Pharmaceutical Industries Ltd, Key Employee Biographies 7
Emzor Pharmaceutical Industries Ltd, Major Products and Services 8
Emzor Pharmaceutical Industries Ltd, History 10
Emzor Pharmaceutical Industries Ltd, Subsidiaries 11
Emzor Pharmaceutical Industries Ltd, Key Competitors 18

★海外企業調査レポート[Emzor Pharmaceutical Industries Ltd:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Intrum Justitia AB:企業のM&A・事業提携・投資動向
    Intrum Justitia AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Intrum Justitia AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Rocket Software, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Rocket Software, Inc. Mergers a …
  • Camargo Correa S.A.:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Camargo Correa S.A." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follo …
  • Danaher Corporation (DHR)-医療機器分野:企業M&A・提携分析
    Summary Danaher Corporation (Danaher) is a medical technology company which designs, manufactures and markets medical, professional, commercial and industrial products and services. The company offers a wide range of testing instruments, communications solutions, water quality systems, medical diagn …
  • GeoPharma, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' GeoPharma, Inc. Mergers and Acq …
  • Associated Banc-Corp.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Associated Banc-Corp. Mergers a …
  • Gaon Cable Co., Ltd. (000500):企業概要、財務及び戦略的SWOT分析
    Summary Gaon Cable Co., Ltd. (Gaon Cable) is an electrical component company. The company develops and supplies industrial power cables. Its products include extra-high voltage cables, overhead lines, MV/LV cables, industrial specialty cables, communication cables, optical communication components, …
  • Aphios Corporation:製品開発パイプライン動向2015
    Aphios Corporation - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Aphios Corporation - Product Pipeline Review - 2015’, provides an overview of the Aphios Corporation’s pharmaceutical research and development focus. This report provides comprehensive information on the current th …
  • Aerie Pharmaceuticals Inc (AERI):製薬・医療:M&Aディール及び事業提携情報
    Summary Aerie Pharmaceuticals Inc (Aerie) is a pharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with glaucoma and other diseases of the eye. The company’s product candidates comprise rhopressa, a once-daily eye drop which is used for the redu …
  • National Fertilizers Limited (NFL):企業の財務及び戦略的SWOT分析
    Summary National Fertilizers Limited (NFL) is a chemical company that manufactures urea and bio-fertilizers. The company’s products include Kisan urea, Neem coated urea, bio-fertilizers, industrial products and traded products. It offers bio-fertilizer such as nitrogenbio-fertilizer and phosphorous …
  • Arabian Pipes Co. (2200):企業財務及び戦略的SWOT分析
    Summary Arabian Pipes Co. (APC) is a clean technology company that develops and distributes welded steel pipes. The company provides welded steel piped such as ERW pipes, LSAW pipes, coating steel pipes, threading and coupling lines; and slitting pipes. Its projects comprise jazan refinery and termi …
  • Toagosei Co., Ltd.:企業の戦略・SWOT・財務分析
    SummaryToagosei Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • Harvard Bioscience Inc (HBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Harvard Bioscience Inc (Harvard Bioscience) develops, manufactures and markets scientific instruments systems and lab consumables. The company’s product portfolio encompasses physiology, cell, molecular instruments products; electrophysiology products; and laboratory products and supplies. I …
  • American Medical Systems, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' American Medical Systems, Inc. …
  • Janssen Pharmaceuticals, Inc.:企業のM&A・提携・投資分析
    Janssen Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Janssen Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Bayer AG (BAYN):製薬・医療:M&Aディール及び事業提携情報
    Summary Bayer AG (Bayer) carries out the research, development, production and commercialization of products for human and animal health care, and agriculture. It provides medicines for cardiovascular diseases, women’s health, cancer, hematology, ophthalmology and other indications. The company's pr …
  • Sumitomo Realty & Development Co., Ltd.:企業の戦略・SWOT・財務情報
    Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Aquila Resources Limited:企業の戦略・SWOT・財務分析
    SummaryAquila Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …
  • Diffusion Pharmaceuticals Inc (DFFN):製薬・医療:M&Aディール及び事業提携情報
    Summary Diffusion Pharmaceuticals Inc (Diffusion), formerly Diffusion Pharmaceuticals LLC is a clinical stage biotechnology company that develops standard of care therapies. The company improves cancer treatments such as radiation therapy and chemotherapy in treatment-resistant solid tumors, includi …
  • Akari Therapeutics Plc (AKTX):企業のM&A・提携動向(医療分野)
    Summary Akari Therapeutics Plc (Akari), formerly Celsus Therapeutics Plc, is a biopharmaceutical company which focuses on the development and commercialization of treatments for rare and orphan autoimmune and inflammatory diseases. Its lead drug, coversin, an inhibitor, acts on complement component- …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆